Long Axial Field of View PET/CT: Technical Aspects in Cardiovascular Diseases [0.03%]
长轴向视野PET/CT在心血管疾病中的技术应用
Tonantzin Samara Martinez-Lucio,Oscar Isaac Mendoza-Ibañez,Wanling Liu et al.
Tonantzin Samara Martinez-Lucio et al.
Positron emission tomography / computed tomography (PET/CT) plays a pivotal role in the assessment of cardiovascular diseases (CVD), particularly in the context of ischemic heart disease. Nevertheless, its application in other forms of CVD,...
Copper-64 Based PET-Radiopharmaceuticals: Ways to Clinical Translational [0.03%]
基于铜-64的PET放射药物：临床转化途径
Nan Yang,Xiao-Yi Guo,Jin Ding et al.
Nan Yang et al.
Positron emission tomography (PET) as an advanced noninvasive imaging technique, provides unprecedented insights into the study of physiological and biochemical processes in vivo. Copper-64 (64Cu) has a ideal half-life of 12.7 hours, with ...
Total Body Positron Emission Tomography/Computed Tomography: Current Status in Oncology [0.03%]
全身正电子发射断层扫描/计算机体层摄影在肿瘤学的现状
Cristina Nanni,Andrea Farolfi,Paolo Castellucci et al.
Cristina Nanni et al.
Positron Emission Tomography (PET) is a crucial imaging modality in oncology, providing functional insights by detecting metabolic activity in tissues. Total-body (TB) PET and large field-of-view PET have emerged as advanced techniques, off...
Non-FDG hypoxia tracers [0.03%]
非FDG乏氧示踪剂
Kgomotso M G Mokoala,Mike M Sathekge
Kgomotso M G Mokoala
Hypoxia plays a critical role in tumor biology, influencing cancer progression, treatment resistance, and patient prognosis. While 18-Fluorine fluoredeoxyglucose ([18F]F-FDG) PET imaging has been the standard for metabolic assessment, its l...
Indraja D Dev,Ameya D Puranik,Baljinder Singh et al.
Indraja D Dev et al.
Programmed Death 1 (PD1) and Programmed Death Ligand (PDL1) play a crucial role in tumor microenvironment by helping cancer cells evade innate immunity. Numerous inhibitor anticancer drugs targeting this interplay have been used in clinical...
Letter From the Editors [0.03%]
编者来信
M Michael Sathekge,Kirsten Bouchelouche
M Michael Sathekge
Esther Mena,Liza Lindenberg,Peter L Choyke
Esther Mena
The increased use of prostate-specific membrane antigen (PSMA) based PET imaging for prostate cancer (Pca) detection has revolutionized the clinical management of Pca, with higher diagnostic sensitivity for extraprostatic disease and increa...
Clinical Explorations of [68Ga] Ga-FAPI-04 and [18F] FDG Dual-Tracer Total-body PET/CT and PET/MR Imaging [0.03%]
[68Ga] Ga-FAPI-04 和 [18F] FDG 双示踪剂全身PET/CT和PET/MR影像的临床探索
Yu Lin,Huaping Gao,Jiefu Zheng et al.
Yu Lin et al.
Fibroblast activation protein inhibitor (FAPI) and [18F]fluorodeoxyglucose ([18F]FDG) provide complementary biological information, and FAPI/FDG dual-tracer imaging clinical application is increasing recently. However, optimal protocols for...
Emerging TSPO-PET Radiotracers for Imaging Neuroinflammation: A Critical Analysis [0.03%]
TSPO正电子发射断层扫描放射性示踪剂在神经炎症成像中的 critical analysis：一种批判分析方法
Grace A Cumbers,Edward D Harvey-Latham,Michael Kassiou et al.
Grace A Cumbers et al.
The translocator protein (TSPO) is a biomarker for imaging neuroinflammation via Positron Emission Tomography (PET) across a broad range of CNS conditions. Most clinically used PET ligands targeting TSPO have limitations, including high lip...
Highlighting New Research Trends on Zirconium-89 Radiopharmaceuticals Beyond Antibodies [0.03%]
抗体以外的放射性药物的新研究趋势的89锆高亮显示
Janie Duvenhage,Maryke Kahts,Beverley Summers et al.
Janie Duvenhage et al.
Zirconium-89 (89Zr) is a cyclotron-produced positron-emitting radioisotope with a half-life of 3.27 days, which makes delayed or longitudinal imaging possible. It is a superior isotope for tracking particles over several days at a high sens...